Published in J Intern Med on January 01, 2000
Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther (2013) 2.06
Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics (2006) 1.67
Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol (2007) 1.12
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis (2015) 1.06
Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol (2010) 1.02
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut (2005) 1.00
Osteoporosis and gastrointestinal disease. Gastroenterol Hepatol (N Y) (2010) 0.99
High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int (2008) 0.97
Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis (2006) 0.95
Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol (2009) 0.92
Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol (2008) 0.92
Bone density and bone metabolism in patients with inflammatory bowel disease. Saudi J Gastroenterol (2012) 0.89
Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol (2014) 0.87
Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci (2014) 0.87
categoryCompare, an analytical tool based on feature annotations. Front Genet (2014) 0.87
Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients (2016) 0.85
Osteoporosis in adult Sri Lankan inflammatory bowel disease patients. World J Gastroenterol (2009) 0.85
Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis (2013) 0.84
Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease. Saudi J Gastroenterol (2012) 0.81
Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factors. Ann Gastroenterol (2011) 0.80
Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol (2015) 0.80
Vitamin d and inflammatory bowel disease. Biomed Res Int (2015) 0.76
Spine bone mineral density and VDR polymorphism in subjects with ulcerative colitis. J Bone Miner Metab (2009) 0.75
Sex-Specific Issues in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2015) 0.75
Low bone mass in microscopic colitis. BMC Gastroenterol (2011) 0.75
Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. Medicine (Baltimore) (2017) 0.75
The Role of Vitamin D in Inflammatory Bowel Disease. Healthcare (Basel) (2015) 0.75
Correlation between low bone density and disease activity in patients with ulcerative colitis. Middle East J Dig Dis (2015) 0.75
Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions? World J Gastroenterol (2016) 0.75
An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease. Dig Dis Sci (2015) 0.75
Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission. Osteoporos Int (2017) 0.75
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 3.74
Systematic review: gastro-oesophageal reflux disease and dental lesions. Aliment Pharmacol Ther (2008) 2.56
Gastroscopic evaluation of anti-inflammatory agents. Br Med J (1980) 2.51
Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'. Aliment Pharmacol Ther (2007) 2.20
An immunoendocrinological hypothesis of HIV infection. Lancet (1994) 2.19
Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest (1994) 2.01
Gastroepiploic artery free graft for coronary bypass. Eur J Cardiothorac Surg (1990) 1.94
Gastroscopy in elderly patients. Curr Med Res Opin (1982) 1.89
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut (2005) 1.84
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Selectins: a family of adhesion receptors. Cell (1991) 1.72
Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64
Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63
Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis (2003) 1.61
Multiple ulcerative esophagitis caused by alendronate. Am J Gastroenterol (1995) 1.60
From endothelial dysfunction to atherosclerosis. Autoimmun Rev (2010) 1.47
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
Effect of fluvastatin on lipids and fibrinolysis in coronary artery disease. Am J Cardiol (1997) 1.46
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J Intern Med (2000) 1.44
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group. Am J Gastroenterol (1998) 1.43
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol (1999) 1.42
Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther (2003) 1.40
The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases. Endoscopy (1995) 1.40
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol (1997) 1.40
Sucralfate and hydrocortisone enemas in the treatment of active ulcerative proctitis--a randomized single-blind comparative study. Aliment Pharmacol Ther (1996) 1.39
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? Dig Liver Dis (2000) 1.39
Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut (1991) 1.38
Pretreatment endoscopy--pro & contra: endoscopy is needed before treatment in all patients with gastroesophageal reflux disease. Endoscopy (2006) 1.38
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35
Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol (1987) 1.34
Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol (1996) 1.33
Ultrasonographic detection of intestinal complications in Crohn's disease. Dig Dis Sci (1996) 1.25
Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med (2002) 1.23
Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut (1985) 1.20
Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol (1991) 1.15
Prevalence and clinical features of heterotopic gastric mucosa in the upper oesophagus (inlet patch). Eur J Gastroenterol Hepatol (2000) 1.12
Campylobacter pylori and ulcer recurrence. Lancet (1988) 1.11
Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut (1991) 1.11
The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration (1992) 1.08
Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford) (2003) 1.08
Preparation, premedication and surveillance. Endoscopy (2003) 1.07
Preparation, premedication, and surveillance. Endoscopy (2005) 1.07
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol (2001) 1.07
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther (2003) 1.06
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab (1979) 1.06
Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol (2003) 1.06
Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol (2000) 1.05
Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone (1996) 1.04
Cerebral metabolism after portacaval shunt. Lancet (1969) 1.03
Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03
Kaposi's sarcoma and AIDS: frequency of gastrointestinal involvement and its effect on survival. A prospective study in a heterogeneous population. Scand J Gastroenterol (1991) 1.03
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol (1998) 1.03
Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet (1984) 1.03
High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int (1999) 1.02
Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther (2003) 1.02
Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis (2005) 1.02
Plasma-prolactin and cimetidine. Lancet (1977) 1.02
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol Suppl (1994) 1.01
Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol (2000) 1.01
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig Liver Dis (2003) 1.01
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology (1999) 1.01
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm Bowel Dis (2007) 0.99
Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage (2001) 0.99
Pirenzepine in the treatment of peptic ulcer disease. Review and commentary. Scand J Gastroenterol Suppl (1982) 0.97
Description of new "bowel-sparing" techniques for long strictures of Crohn's disease. Am J Surg (1997) 0.97
Is maintenance therapy always necessary for patients with ulcerative colitis in remission? Aliment Pharmacol Ther (1999) 0.96
Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J Clin Gastroenterol (1986) 0.96
Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on. Dig Liver Dis (2004) 0.96
Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol (1997) 0.96
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther (2002) 0.95
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Aliment Pharmacol Ther (2005) 0.95
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol (2009) 0.95
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol (1991) 0.95
Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis. Scand J Gastroenterol (1999) 0.94
Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn's disease using "bowel-sparing" techniques. Am J Surg (2000) 0.94
Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res (1989) 0.94